Novel fibrinogen truncation with deletion of Bβ chain residues 440-461 causes hypofibrinogenaemia

Thrombosis and Haemostasis

Volumn 88, Issue 3, 2002, Pages 427-431

  Homer, Vivienne M ^a   Brennan, Stephen O ^a   Ockelford, Paul ^a   George, Peter M ^a  

^a CANTERBURY HEALTH LABORATORIES   (New Zealand)

Author keywords

Chain truncation; D domain; Hypofibrinogenaemia; Mass spectrometry; Strand deletion

Indexed keywords

FIBRIN; FIBRINOGEN; INTERFERON; NUCLEOTIDE; RIBAVIRIN; FIBRINOGEN VARIANT;

ADULT; ALPHA CHAIN; ARTICLE; BETA CHAIN; CASE REPORT; CELL INCLUSION; CHROMOSOME ABERRATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DNA SEQUENCE; EXON; FIBRIN POLYMERIZATION; FIBRINOGEN BLOOD LEVEL; GENE DELETION; GENE MUTATION; GRAVIMETRY; HEPATITIS C; HETEROZYGOTE DETECTION; HUMAN; HYPOFIBRINOGENEMIA; INTRON; LIVER BIOPSY; MALE; MASS SPECTROMETRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; STOP CODON; STRUCTURE ANALYSIS; AFIBRINOGENEMIA; AMINO ACID SEQUENCE; BLOOD CLOTTING TEST; CHEMISTRY; DIMERIZATION; GENETICS; HETEROZYGOTE; KINETICS; METABOLISM; NUCLEOTIDE SEQUENCE; POINT MUTATION; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE;

ADULT; AFIBRINOGENEMIA; AMINO ACID SEQUENCE; BLOOD COAGULATION TESTS; CODON, NONSENSE; DIMERIZATION; DNA MUTATIONAL ANALYSIS; FIBRINOGENS, ABNORMAL; HETEROZYGOTE; HUMANS; KINETICS; MALE; POINT MUTATION; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; SEQUENCE DELETION;

EID: 0036713664     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613233     Document Type: Article

References (26)

1. The molecular biology of fibrin
2. Fibrinogen, fibrin and factor XIII
3. Biosynthesis of human fibrinogen. Subunit interactions and potential intermediates in the assembly
4. The role of βγ and αγ complexes in the assembly of human fibrinogen
5. Ubiquitin and the control of protein fate in the secretory and endocytic pathways
6. Fibrinogen Brescia: Hepatic endoplasmic reticulum storage and hypofibrinogenemia because of a γ284 Gly→Arg mutation
7. Hepatic endoplasmic reticulum storage diseases
8. Fibrinogen Otago: A major α chain truncation associated with severe hypofibrinogenaemia and recurrent miscarriage
9. Hypofibrinogenaemia with compound heterozygosity for two gamma chain mutations - Gamma 82 Ala→Gly and an intron two GT→AT splice site mutation
10. Hypofibrinogenemia due to novel 316 Asp→Tyr substitution in the fibrinogen Bbeta chain
11. Missense mutations in the human β fibrinogen gene cause congenital afibrinogenemia by impairing fibrinogen secretion
12. Aberrant hepatic processing causes removal of activation peptide and primary polymerisation site from fibrinogen Canterbury (Aα20 Val→Asp)
13. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
14. Characterization of fibrinogen Milano I: Amino acid exchange γ330 Asp→Val impairs fibrin polymerization
15. Electrospray ionisation analysis of human fibrinogen
16. Electrospray ionisation mass spectrometry facilitates detection of fibrinogen (Bβ 14Arg→Cys) mutation in a family with thrombosis
17. A simple method for DNA purification from peripheral blood
18. Diagnosis of sickle cell anemia and beta-thalassemia with enzymatically amplified DNA and nonradioactive allele-specific oligonucleotide probes
19. Fibrinogen inclusions in liver cells: A new type of ground-glass hepatocyte. Immune light and electron microscopic characterization
20. The role of sialic acid in the dysfibrinogenemia associated with liver disease: Distribution of sialic acid on the constituent chains
21. Role of the beta-strand insert in the central domain of the fibrinogen gamma-module
22. The covalent structure of Factor XIIIa crosslinked fibrinogen fibrils
23. The location of the carboxy-terminal region of γ chains in fibrinogen and fibrin D domains
24. Involvement of fibrinogen Bβ-chain gene in the pathogenesis of congenital afibrinogenaemia
25. SWISS-MODEL and the Swiss-Pdb Viewer: An environment for comparative protein modelling
26. Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin